Asynchronous Messaging Therapy for Depression and Anxiety: A Longitudinal Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Depressive Symptoms
- Sponsor
- Talkspace
- Enrollment
- 12980
- Primary Endpoint
- Change from Baseline in Anxiety symptoms on the Generalized Anxiety Disorder - 7
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
Therapies delivered via technology have been developed to improve accessibility, however, there is limited research regarding messaging therapy in particular, and none that we know of utilizing a longitudinal effectiveness design. The aim of this study was to investigate the overall effectiveness of messaging therapy, identify any contributors to its effectiveness, and to evaluate a dosage effect for this type of treatment.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diagnosed Depression and/or Anxiety Disorder
Exclusion Criteria
- •Any psychosis related symptoms or disorders
Outcomes
Primary Outcomes
Change from Baseline in Anxiety symptoms on the Generalized Anxiety Disorder - 7
Time Frame: Up to 52 weeks
Generalized Anxiety Disorder - 7 (GAD-7) is a measure of anxiety symptoms. It has 7 items, with a minimum of 0 and a maximum of 21, with higher scores indicating more symptoms and distress. Decreasing scores indicate better outcome. All items are summed to give the summary score.
Change from Baseline in Depressive symptoms on the Patient Health Questionnaire - 9
Time Frame: Up to 52 weeks
Patient Health Questionnaire - 9 (PHQ-9) is a measure of depression symptoms. It has 9 items, with a minimum of 0 and a maximum of 27, with higher scores indicating more symptoms and distress. Decreasing scores indicate better outcome. All items are summed to give the summary score.
Secondary Outcomes
- Mean number of words sent from therapist to patient(Up to 52 weeks)
- Mean number of words sent from patient to therapist(Up to 52 weeks)